Target Name: PDZPH1P
NCBI ID: G105379197
Review Report on PDZPH1P Target / Biomarker Content of Review Report on PDZPH1P Target / Biomarker
PDZPH1P
Other Name(s): PDZ and pleckstrin homology domains 1, pseudogene

PDZPH1P: A Potential Drug Target and Biomarker for various Diseases

PDZPH1P, also known as PDZ and pleckstrin homology domains organs 1, is a protein that is expressed in various tissues and throughout the body. It is a member of the PDZ family of proteins, which are known for their role in cell signaling and development. PDZPH1P has been identified as a potential drug target and may also be a biomarker for various diseases.

The PDZ family of proteins is characterized by the presence of a unique transmembrane domain and a C-terminal region that contains a nucleotide-binding oligomerization domain (NBD) and a pleckstrin homology domain (PHD). The NBD is responsible for the protein's ability to interact with intracellular signaling molecules, while the PHD is involved in the protein's stability and functions as a scaffold.

PDZPH1P is a 21-kDa protein that is expressed in various tissues, including brain, heart, liver, and pancreas. It is primarily localized to the endoplasmic reticulum (ER) and is thought to play a role in intracellular signaling. PDZPH1P has been shown to interact with various signaling molecules, including cAMP-dependent protein kinase (PKA), which is involved in cell signaling and development.

In addition to its role in intracellular signaling, PDZPH1P has also been shown to be involved in the regulation of various cellular processes, including cell adhesion, migration, and invasion. It has been shown to interact with various cell adhesion molecules, including cadherin and E -cadherin, which are involved in cell-cell adhesion. PDZPH1P has also been shown to be involved in the regulation of cell migration and invasion, as well as the formation of cancer stem cells.

PDZPH1P has also been shown to play a role in the regulation of various signaling pathways that are involved in cancer development. For example, it has been shown to be involved in the regulation of the PI3K/Akt signaling pathway, which is involved in cell signaling and survival. PDZPH1P has also been shown to interact with the protein inhibitor of and tyrosine-protein kinase (IP3K), which is involved in the regulation of various cellular processes, including cell signaling and survival.

In addition to its role in intracellular signaling and cancer development, PDZPH1P has also been suggested as a potential drug target. Several studies have shown that inhibiting the activity of PDZPH1P can have a variety of cellular and molecular effects, including the inhibition of cell proliferation, the inhibition of cell migration, and the inhibition of the formation of cancer stem cells. In addition, PDZPH1P has been shown to interact with various drug targets, including the protein inhibitor of and tyrosine-protein kinase (IP3K), which is involved in the regulation of various cellular processes, including cell signaling and survival.

PDZPH1P may also be a potential biomarker for various diseases. For example, it has been shown to be involved in the regulation of various cellular processes that are involved in cancer development, including the regulation of cell signaling and survival. PDZPH1P may also be involved in the regulation of cell adhesion, migration, and invasion, which are important processes in the development of cancer. In addition, PDZPH1P may be involved in the regulation of various signaling pathways that are involved in cancer development, including the PI3K/Akt signaling pathway.

In conclusion, PDZPH1P is a protein that is expressed in various tissues and organs throughout the body and is involved in intracellular signaling and the regulation of various cellular processes, including cell adhesion, migration, and invasion. It has been shown to interact with various signaling molecules and may be a potential drug target and biomarker for various diseases. Further research is needed to fully understand the role of PDZPH1P in

Protein Name: PDZ And Pleckstrin Homology Domains 1, Pseudogene

The "PDZPH1P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PDZPH1P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

PDZRN3 | PDZRN3-AS1 | PDZRN4 | PEA15 | PEAK1 | PEAK3 | PEAR1 | PeBoW complex | PEBP1 | PEBP1P2 | PEBP4 | PECAM1 | PECR | PEDS1 | PEDS1-UBE2V1 | PEF1 | PEG10 | PEG13 | PEG3 | PEG3-AS1 | PELATON | PELI1 | PELI2 | PELI3 | PELO | PELP1 | PELP1-DT | PEMT | PENK | PENK-AS1 | PEPD | Peptidyl arginine deiminase (PAD) | Peptidylprolyl Isomerase | PER1 | PER2 | PER3 | PER3P1 | PERM1 | Peroxiredoxin | Peroxisome Proliferator-Activated Receptors (PPAR) | PERP | PES1 | PET100 | PET117 | PEX1 | PEX10 | PEX11A | PEX11B | PEX11G | PEX12 | PEX13 | PEX14 | PEX16 | PEX19 | PEX2 | PEX26 | PEX3 | PEX5 | PEX5L | PEX5L-AS2 | PEX6 | PEX7 | PF4 | PF4V1 | PFAS | PFDN1 | PFDN2 | PFDN4 | PFDN5 | PFDN6 | PFKFB1 | PFKFB2 | PFKFB3 | PFKFB4 | PFKL | PFKM | PFKP | PFN1 | PFN1P2 | PFN1P3 | PFN1P4 | PFN1P6 | PFN1P8 | PFN2 | PFN3 | PFN4 | PGA3 | PGA4 | PGA5 | PGAM1 | PGAM1P5 | PGAM1P7 | PGAM1P8 | PGAM2 | PGAM4 | PGAM5 | PGAM5-KEAP1-NRF2 Complex | PGAP1 | PGAP2 | PGAP3